Advertisement
Advertisement
U.S. Markets open in 7 hrs 44 mins
Advertisement
Advertisement
Advertisement
Advertisement

Orthofix Medical Inc. (OFIX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
27.23-0.55 (-1.98%)
At close: 04:00PM EDT
27.23 0.00 (0.00%)
After hours: 04:19PM EDT
Advertisement

Orthofix Medical Inc.

3451 Plano Parkway
Lewisville, TX 75056
United States
214 937 2000
https://www.orthofix.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees1,087

Key Executives

NameTitlePayExercisedYear Born
Mr. Jon C. SerbousekPres, CEO & Director1.57MN/A1961
Mr. Douglas C. RiceCFO & Chief Accounting Officer764.47kN/A1966
Ms. Kimberley A. EltingChief Legal & Devel. Officer and Pres of the Global Orthopedics761.61kN/A1965
Mr. Kevin J. KennyPres of Global Spine Bus.882.14kN/A1965
Mr. Roberto DonadelloSr. VP of Global OperationsN/AN/AN/A
Dr. James T. Ryaby B.A., Chemistry, Ph.D.Chief Scientific OfficerN/AN/A1959
Mr. Dan E. YarbroughVP of Investor RelationsN/AN/AN/A
Ms. Jill MasonChief Ethics & Compliance OfficerN/AN/AN/A
Ms. Suzanne ArmstrongVP of HRN/AN/AN/A
Mr. Ehab M. EsmailSr. VP of Quality, Regulatory & Clinical AffairsN/AN/A1972
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Corporate Governance

Orthofix Medical Inc.’s ISS Governance QualityScore as of May 1, 2022 is 1. The pillar scores are Audit: 3; Board: 1; Shareholder Rights: 2; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement